Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference5 articles.
1. The ESMO call to action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate;Garassino;Ann Oncol,2021
2. Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment;Peeters;ESMO Open,2021
3. Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study;Fendler;Nat Cancer,2021
4. Antibody titers before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in cancer patients;Debie;Eur J Cancer,2022
5. Efficacy of SARS-CoV-2 vaccine in thoracic cancer patients: a prospective study supporting a third dose in patients with minimal serologic response after two vaccine doses;Gounant;J Thorac Oncol,2022
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-term effects of the COVID-19 pandemic for patients with cancer;Quality of Life Research;2024-07-03
2. Humoral Response after SARS-CoV-2 Vaccination in Prostate Cancer Patients;Vaccines;2023-03-30
3. Early COVID-19 booster is beneficial in cancer patients;Annals of the Academy of Medicine, Singapore;2023-01-30
4. Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with Cancer;Clinical Cancer Research;2022-11-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3